Search

everythinglearnresearchcommunity

for

Search:↓

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

JAK inhibitors may help improve symptoms in adults with APECED.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

A woman with Lupus Vasculitis improved after treatment with steroids and other medications.

A multi-tiered treatment approach is crucial for managing hidradenitis suppurativa in patients with intellectual and developmental disabilities.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Patients with ichthyosis often experience symptoms similar to psoriasis and atopic dermatitis, suggesting that targeted therapies could improve their condition.

AGA patients have a lower quality of life than AA patients.

No single biomarker is reliable enough for diagnosing and assessing SLE.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

A comprehensive approach is needed to accurately assess alopecia areata severity and guide treatment decisions.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Baricitinib is the most effective treatment for alopecia areata.

Self-assessed hirsutism scores are not reliable for clinical diagnosis but may help in screening.

Costovertebral arthritis can cause chronic back pain in SLE patients and needs thorough evaluation.

SLE can occur in young males and cause knee pain.